Clinical Trial Update: A Phase 4 Clinical Study of Brodalumab [Phase 4]

View source ↗

Summary

A Phase 4 clinical study of brodalumab completed, investigating psoriasis vulgaris and psoriatic arthritis (with related pustular and erythrodermic variants men…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Psoriasis Palmaris Et Plantaris
• Psoriasis Vulgaris
• Psoriatic Arthritis
• Psoriatic Erythroderma
• Pustular Psoriasis

Drugs mentioned

• brodalumab (brodalumab)

Snippet

Sponsor: Kyowa Kirin Co., Ltd. | Conditions: Psoriasis Vulgaris, Psoriatic Arthritis | Phase 4 | Status: COMPLETED